Rising health awareness, increasing prevalence of various forms of mucopolysaccharidosis worldwide, continuous advances in ...

In a report released yesterday, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – ...

A five year-old boy with a life-limiting metabolic disorder is celebrating Christmas, after a vital stem cell transplant. In ...

Principal Financial Group Inc. raised its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 740.0% ...

CEO Emil D. Kakkis sold 11,727 shares of the stock in a transaction dated Monday, December 30th. The stock was sold at an ...

On a recent visit to Washington DC, Ho sat down with GEN Editorial Director Kevin Davies, PhD, to discuss Denali’s progress ...

Photo courtesy of Munya Visual Factory The three Oak Bay kids – Spencer, 9, and twins Isabel and Simon, 6, – are also pretty ...

Simon Hoskins, 8, and his family – including twin sister Isabel and older brother Spencer – embarked on a similar venture, ...

Ultragenyx Pharmaceutical RARE announced that the European Commission (EC) has expanded the eligible patient population for ...